A 51-year-old woman who has been receiving estrogen and progesterone therapy (EPT) for the last 5 years has visited her care provider
because her peers have told her about the risks of heart disease, stroke, and breast cancer that could accompany hormone therapy (HT). How should her care provider respond to her concerns?
A)
There is a demonstrable increase in breast cancer risk with HT, but the risk of stroke or heart disease actually go down slightly.
B)
All considered, the benefits of HT outweigh the slightly increased risks of heart disease, stroke, or breast cancer.
C)
HT is actually associated with a decrease in heart disease risk, but there is an increase in stroke risk; the breast cancer connection is still unclear.
D)
There's in fact a slight protective effect against stroke associated with HT, but this is partially offset by increased rates of heart disease and breast cancer.
Question 2
A 39-year-old male client has been recently diagnosed with primary hypogonadism. Which of the following lab results would be most indicative of this diagnosis?
A)
Normal levels of free testosterone; low levels of total testosterone
B)
Low free testosterone, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) levels
C)
Low levels of gonadotropin-releasing hormone (GnRH)
D)
Low testosterone levels; high levels of LH and FSH
Complementary and Alternative Therapy Use Among Adults and Children
Head of A Woman
Ex vivo and in vivo gene therapy for a patient with a liver disorder
Gene therapy can prevent progression of metachromatic leukodystrophy
Dragon Chinese new year 2023